IL-1 ligands are able to increase DC maturation and activation [27, 28] which is supported by our in vitro PBMC/cancer cell co-cultures showing IL-1α-induced DC activation (Fig. 2E) and our in vivo results showing DC activation in TDLNs after IL-1αMP treatment (Fig. 4G). This evidence concerns the gene IL1A and cancer.